✏️Prompts
Geneious

Geneious

Bioinformatics software platform for sequence analysis, molecular biology, and genomics research with AI-assisted annotation.

Pricing
$$
Classification
AI-Enhanced
Type
Platform Suite

What it does

Geneious (by Dotmatics) is a bioinformatics software platform used by molecular biologists, geneticists, and genomics researchers for DNA and protein sequence analysis, phylogenetics, primer design, and molecular cloning. AI capabilities include AI-assisted sequence annotation that predicts gene features and functional elements from sequence data, ML-powered variant calling that identifies mutations in sequencing data with improved sensitivity over traditional methods, automated primer design that generates optimal PCR primers for any target sequence, intelligent sequence assembly that reconstructs genomes from sequencing reads, and AI-powered antibody sequence analysis for therapeutic antibody development programs.

Why AI-ENHANCED

Geneious is an established bioinformatics platform that has integrated AI sequence annotation, ML variant calling, and automated primer design into a mature molecular biology and genomics analysis product.

Best for

Mid-Market

Pharmaceutical discovery teams and academic research labs use Geneious for molecular biology data analysis - AI sequence analysis reducing bioinformatics bottlenecks in drug discovery workflows.

Enterprise

Large pharmaceutical companies and genomics companies use Geneious for enterprise bioinformatics - AI-assisted analysis across large genomic datasets and antibody analysis supporting therapeutic development programs.

Limitations

Bioinformatics and molecular biology focus only

Geneious is purpose-built for biological sequence analysis — non-biology research, clinical genomics patient care, and other life sciences applications have different tooling requirements.

Computational biology expertise required

Geneious's AI tools accelerate expert bioinformatics work — researchers without molecular biology and bioinformatics training cannot productively use the platform's analytical capabilities independently.

Dotmatics acquisition creates portfolio integration questions

Geneious is part of Dotmatics' R&D software portfolio — buyers should assess product roadmap continuity and integration with Dotmatics' broader scientific data platform.

Alternatives by segment

If you need…Consider instead
Laboratory data management platformBenchling
Genomics data analysisIllumina
Drug discovery AI platformBenevolentAI
Pricing

Geneious Prime from $1,540/user/year. Research licenses for academic use at lower rates. Enterprise team pricing negotiated. Annual contracts.

Key integrations
Illumina
AWS
NCBI
UniProt
Benchling